NEWS
Afrigen Biologics and Dillico sign CRADA to advance mRNA manufacturing solutions
Afrigen Biologics, the development lead in the mRNA technology transfer programme and Dillico Announce Cooperative R&D Agreement to test a new continuous mRNA Manufacturing Solution adapted for low- and middle-income countries. Cape Town, South Africa - and Grenoble , France , May 2023 Afrigen Biologics and Vaccines, a biotechnology [...]
Flora Binder to join Dillico as Chief Development Officer
We are pleased to announce today that Flora Binder has taken up her role of Dillico’s Chief Development Officer. “Flora has a solid expertise in mRNA process transfer in the global pharmaceutical industry and it will be a significant asset to Dillico to advance our vision to modernize mRNA-LNP manufacturing. On behalf of our team, I want to warmly welcome Flora as a new member of the management,” said Christophe Bonneville, [...]
French Tech Emergence Grant for Dillico
Dillico is pleased to announce that it has been awarded a French Tech Emergence grant by BPIFrance, which we thank. This financial support is granted to startup projects that develop a disruptive innovation with high technological content. It allows to conduct feasibility studies still needed. Dillico will use this [...]